News
10 May 2019
CANTAB Research Grant 2019 - Results
The results of the 2019 CANTAB Research Grant are in! Once again we were overwhelmed by the quality of applications we received – which made it a tough job for our judging panel to narrow the research proposals down.
Read on
19 March 2019
Cambridge Cognition wins significant new digital health contract worth £1.3m
Cambridge Cognition has announced a significant new contract providing digital health technologies to a major pharmaceutical company for application in a clinical stage development programme.
Read on
7 March 2019
Cambridge Cognition appoints new Chief Operating Officer
Cambridge Cognition is pleased to announce that Dr Matthew Stork has agreed to join the Company as Chief Operating Officer on completion of the fundraise announced earlier today.
Read on
7 March 2019
Cambridge Cognition fundraising efforts generate £2.5m
Cambridge Cognition has announced that it has raised total gross proceeds of £2.5 million through an oversubscribed placing of 3,437,500 new ordinary shares (“Placing Shares”) of 1 pence each in the capital of the Company (“Ordinary Shares”) at a price of 72 pence per Ordinary Share (the “Issue Price”); and a subscription for 34,723 Ordinary Shares (the “Subscription Shares”) also at the Issue Price (the “Subscription”) (the Subscription and the Placing together, the “Fundraising”).
finnCap Ltd and Dowgate Capital Limited acted as joint bookrunners to the Company (the “Bookrunners”).
Read on
7 March 2019
Cambridge Cognition sales orders up 49% to £7.93m
Cambridge Cognition announced preliminary results for the year ended 31 December 2018 with sales orders up 49% to £7.93m.
Read on
31 January 2019
Cambridge Cognition announces first partnership in India
Cambridge Cognition has announced a partnership with a major pharmaceutical company to deliver online neurological testing to patients in India using the Company’s cloud-based CANTAB Connect platform.
